BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 22454484)

  • 1. Reproducibility of tumor uptake heterogeneity characterization through textural feature analysis in 18F-FDG PET.
    Tixier F; Hatt M; Le Rest CC; Le Pogam A; Corcos L; Visvikis D
    J Nucl Med; 2012 May; 53(5):693-700. PubMed ID: 22454484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intratumor heterogeneity characterized by textural features on baseline 18F-FDG PET images predicts response to concomitant radiochemotherapy in esophageal cancer.
    Tixier F; Le Rest CC; Hatt M; Albarghach N; Pradier O; Metges JP; Corcos L; Visvikis D
    J Nucl Med; 2011 Mar; 52(3):369-78. PubMed ID: 21321270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three-dimensional positron emission tomography image texture analysis of esophageal squamous cell carcinoma: relationship between tumor 18F-fluorodeoxyglucose uptake heterogeneity, maximum standardized uptake value, and tumor stage.
    Dong X; Xing L; Wu P; Fu Z; Wan H; Li D; Yin Y; Sun X; Yu J
    Nucl Med Commun; 2013 Jan; 34(1):40-6. PubMed ID: 23111378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reproducibility of F18-FDG PET radiomic features for different cervical tumor segmentation methods, gray-level discretization, and reconstruction algorithms.
    Altazi BA; Zhang GG; Fernandez DC; Montejo ME; Hunt D; Werner J; Biagioli MC; Moros EG
    J Appl Clin Med Phys; 2017 Nov; 18(6):32-48. PubMed ID: 28891217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intra-tumour 18F-FDG uptake heterogeneity decreases the reliability on target volume definition with positron emission tomography/computed tomography imaging.
    Dong X; Wu P; Sun X; Li W; Wan H; Yu J; Xing L
    J Med Imaging Radiat Oncol; 2015 Jun; 59(3):338-45. PubMed ID: 25708154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are pretreatment 18F-FDG PET tumor textural features in non-small cell lung cancer associated with response and survival after chemoradiotherapy?
    Cook GJ; Yip C; Siddique M; Goh V; Chicklore S; Roy A; Marsden P; Ahmad S; Landau D
    J Nucl Med; 2013 Jan; 54(1):19-26. PubMed ID: 23204495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Robustness of intratumour ¹⁸F-FDG PET uptake heterogeneity quantification for therapy response prediction in oesophageal carcinoma.
    Hatt M; Tixier F; Cheze Le Rest C; Pradier O; Visvikis D
    Eur J Nucl Med Mol Imaging; 2013 Oct; 40(11):1662-71. PubMed ID: 23857457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The precision of textural analysis in (18)F-FDG-PET scans of oesophageal cancer.
    Doumou G; Siddique M; Tsoumpas C; Goh V; Cook GJ
    Eur Radiol; 2015 Sep; 25(9):2805-12. PubMed ID: 25994189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting Response to Neoadjuvant Chemoradiotherapy in Esophageal Cancer with Textural Features Derived from Pretreatment
    Beukinga RJ; Hulshoff JB; van Dijk LV; Muijs CT; Burgerhof JGM; Kats-Ugurlu G; Slart RHJA; Slump CH; Mul VEM; Plukker JTM
    J Nucl Med; 2017 May; 58(5):723-729. PubMed ID: 27738011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a cumulative SUV-volume histogram method for parameterizing heterogeneous intratumoural FDG uptake in non-small cell lung cancer PET studies.
    van Velden FH; Cheebsumon P; Yaqub M; Smit EF; Hoekstra OS; Lammertsma AA; Boellaard R
    Eur J Nucl Med Mol Imaging; 2011 Sep; 38(9):1636-47. PubMed ID: 21617975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inter-observer and segmentation method variability of textural analysis in pre-therapeutic FDG PET/CT in head and neck cancer.
    Guezennec C; Bourhis D; Orlhac F; Robin P; Corre JB; Delcroix O; Gobel Y; Schick U; Salaün PY; Abgral R
    PLoS One; 2019; 14(3):e0214299. PubMed ID: 30921388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reproducibility of 18F-FDG and 3'-deoxy-3'-18F-fluorothymidine PET tumor volume measurements.
    Hatt M; Cheze-Le Rest C; Aboagye EO; Kenny LM; Rosso L; Turkheimer FE; Albarghach NM; Metges JP; Pradier O; Visvikis D
    J Nucl Med; 2010 Sep; 51(9):1368-76. PubMed ID: 20720054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 18F-FDG PET uptake characterization through texture analysis: investigating the complementary nature of heterogeneity and functional tumor volume in a multi-cancer site patient cohort.
    Hatt M; Majdoub M; Vallières M; Tixier F; Le Rest CC; Groheux D; Hindié E; Martineau A; Pradier O; Hustinx R; Perdrisot R; Guillevin R; El Naqa I; Visvikis D
    J Nucl Med; 2015 Jan; 56(1):38-44. PubMed ID: 25500829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of partial-volume effect correction on the predictive and prognostic value of baseline 18F-FDG PET images in esophageal cancer.
    Hatt M; Le Pogam A; Visvikis D; Pradier O; Cheze Le Rest C
    J Nucl Med; 2012 Jan; 53(1):12-20. PubMed ID: 22213819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Textural features and SUV-based variables assessed by dual time point 18F-FDG PET/CT in locally advanced breast cancer.
    Garcia-Vicente AM; Molina D; Pérez-Beteta J; Amo-Salas M; Martínez-González A; Bueno G; Tello-Galán MJ; Soriano-Castrejón Á
    Ann Nucl Med; 2017 Dec; 31(10):726-735. PubMed ID: 28887761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spatial and temporal heterogeneity of regional myocardial uptake in patients without heart disease under fasting conditions on repeated whole-body 18F-FDG PET/CT.
    Inglese E; Leva L; Matheoud R; Sacchetti G; Secco C; Gandolfo P; Brambilla M; Sambuceti G
    J Nucl Med; 2007 Oct; 48(10):1662-9. PubMed ID: 17873124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting pathologic tumor response to chemoradiotherapy with histogram distances characterizing longitudinal changes in 18F-FDG uptake patterns.
    Tan S; Zhang H; Zhang Y; Chen W; D'Souza WD; Lu W
    Med Phys; 2013 Oct; 40(10):101707. PubMed ID: 24089897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repeatability of 18F-FDG PET/CT in Advanced Non-Small Cell Lung Cancer: Prospective Assessment in 2 Multicenter Trials.
    Weber WA; Gatsonis CA; Mozley PD; Hanna LG; Shields AF; Aberle DR; Govindan R; Torigian DA; Karp JS; Yu JQ; Subramaniam RM; Halvorsen RA; Siegel BA; ;
    J Nucl Med; 2015 Aug; 56(8):1137-43. PubMed ID: 25908829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multicenter Clinical Trials Using 18F-FDG PET to Measure Early Response to Oncologic Therapy: Effects of Injection-to-Acquisition Time Variability on Required Sample Size.
    Kurland BF; Muzi M; Peterson LM; Doot RK; Wangerin KA; Mankoff DA; Linden HM; Kinahan PE
    J Nucl Med; 2016 Feb; 57(2):226-30. PubMed ID: 26493206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variability of textural features in FDG PET images due to different acquisition modes and reconstruction parameters.
    Galavis PE; Hollensen C; Jallow N; Paliwal B; Jeraj R
    Acta Oncol; 2010 Oct; 49(7):1012-6. PubMed ID: 20831489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.